Free Trial

Curaleaf (OTCMKTS:CURLF) Shares Gap Up - What's Next?

Curaleaf logo with Medical background

Key Points

  • Curaleaf's stock price opened at $3.26 after closing at $3.00, reflecting a positive trading movement with a trading volume of 40,923 shares.
  • Analysts have given Curaleaf a consensus rating of "Strong Buy", with upgrades from Canaccord Genuity Group and Cormark recently enhancing their ratings.
  • In their latest quarterly earnings report, Curaleaf posted an EPS of ($0.06), exceeding expectations of ($0.07), despite negative net margins and anticipated future earnings challenges.
  • MarketBeat previews the top five stocks to own by November 1st.

Curaleaf Holdings, Inc. (OTCMKTS:CURLF - Get Free Report)'s stock price gapped up before the market opened on Monday . The stock had previously closed at $3.00, but opened at $3.26. Curaleaf shares last traded at $3.08, with a volume of 40,923 shares changing hands.

Analysts Set New Price Targets

A number of brokerages have commented on CURLF. Canaccord Genuity Group upgraded shares of Curaleaf to a "strong-buy" rating in a research note on Thursday. Cormark upgraded Curaleaf from a "hold" rating to a "moderate buy" rating in a research report on Friday, August 8th. Two investment analysts have rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock has a consensus rating of "Strong Buy".

Check Out Our Latest Research Report on Curaleaf

Curaleaf Price Performance

The company has a quick ratio of 0.70, a current ratio of 1.47 and a debt-to-equity ratio of 1.00. The firm has a market cap of $2.04 billion, a P/E ratio of -9.48 and a beta of 0.71. The business has a fifty day moving average of $2.76 and a 200 day moving average of $1.57.

Curaleaf (OTCMKTS:CURLF - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported ($0.06) EPS for the quarter, topping analysts' consensus estimates of ($0.07) by $0.01. Curaleaf had a negative net margin of 18.08% and a negative return on equity of 14.61%. On average, sell-side analysts anticipate that Curaleaf Holdings, Inc. will post -0.25 earnings per share for the current year.

About Curaleaf

(Get Free Report)

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Curaleaf Right Now?

Before you consider Curaleaf, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Curaleaf wasn't on the list.

While Curaleaf currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.